HT
ONC

Headlands Technologies’s BeOne Medicines Ltd ONC Stock Holding History

Headlands Technologies’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,773
Closed -$396K – 1610
2024
Q2 		$396K Buy
2,773
+2,451
+761% +$378K 0.04% 325
2024
Q1 		$50.4K Buy
+322
New +$51.8K 0.01% 708
2023
Q4 		– Sell
-129
Closed -$23.2K – 1364
2023
Q3 		$23.2K Sell
129
-94
-42% -$18.6K 0.01% 570
2023
Q2 		$39.8K Buy
+223
New +$51.4K 0.01% 499

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Headlands Technologies's ONC Position: Q3 2024 in Review

Headlands Technologies sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 2,773 shares — an estimated $396K sold.

Headlands Technologies first reported a position in ONC in Q2 2023 and held it in 4 quarters. The position peaked at $396K in Q2 2024. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Headlands Technologies reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Headlands Technologies sold 2,773 BeOne Medicines Ltd shares in Q3 2024, an estimated $396K.
  • Headlands Technologies first reported a position in BeOne Medicines Ltd in Q2 2023 and held it in 4 quarters.
  • Headlands Technologies's BeOne Medicines Ltd position peaked at $396K in Q2 2024.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Headlands Technologies's 13F filing for Q3 2024, filed 12 Nov 2024.